DRTS
Alpha Tau Medical Ltd. NASDAQ Listed Mar 8, 2021$7.85
Mkt Cap $690.9M
52w Low $2.57
81.2% of range
52w High $9.07
50d MA $7.41
200d MA $5.33
P/E (TTM)
-16.1x
EV/EBITDA
-9.7x
P/B
8.9x
Debt/Equity
0.2x
ROE
-55.3%
P/FCF
-12.2x
RSI (14)
—
ATR (14)
—
Beta
1.05
50d MA
$7.41
200d MA
$5.33
Avg Volume
282.9K
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
5 Kiryat Hamada Street · Jerusalem, L3 9777605 · IL
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | AMC | -0.13 | -0.14 | -7.7% | 6.71 | -0.7% | +1.9% | +2.9% | -1.0% | +2.9% | +1.1% | — |
| Nov 20, 2025 | AMC | -0.12 | -0.14 | -16.7% | 3.47 | -1.2% | +10.1% | -4.5% | +6.8% | -4.1% | +6.1% | — |
| Aug 11, 2025 | AMC | -0.12 | -0.13 | -8.3% | 3.56 | -1.7% | -8.7% | +5.2% | -6.4% | +2.5% | -0.6% | — |
| May 19, 2025 | AMC | -0.14 | -0.12 | +14.3% | 3.10 | +4.8% | +5.2% | -4.6% | -3.5% | +0.0% | +2.3% | — |
| Mar 12, 2025 | AMC | -0.13 | -0.13 | +0.0% | 2.66 | +1.1% | -1.5% | +1.1% | +0.4% | -1.5% | -0.8% | — |
| Aug 14, 2024 | AMC | -0.13 | -0.11 | +15.4% | 2.11 | +0.5% | +6.6% | -3.1% | -0.9% | +0.9% | +0.0% | — |
| May 20, 2024 | AMC | -0.13 | -0.11 | +15.4% | 2.71 | +7.4% | +0.0% | +0.0% | -2.2% | -4.5% | -2.4% | — |
| Mar 7, 2024 | AMC | -0.13 | -0.11 | +15.4% | 3.03 | -1.0% | -0.7% | -0.3% | -3.3% | +0.7% | -2.7% | — |
| Nov 16, 2023 | AMC | -0.12 | -0.07 | +41.7% | 2.93 | +0.0% | +4.1% | -4.9% | -3.8% | +7.2% | +1.7% | — |
| Aug 28, 2023 | AMC | -0.13 | -0.12 | +7.7% | 3.25 | +0.6% | +3.1% | -2.7% | +0.6% | +9.5% | -6.4% | — |
| May 23, 2023 | AMC | -0.09 | -0.12 | -33.3% | 3.71 | -2.4% | +3.5% | -1.6% | +2.4% | +1.3% | +1.3% | — |
| Mar 9, 2023 | AMC | -0.12 | -0.04 | +66.7% | 3.30 | +0.9% | -1.5% | -7.4% | +4.5% | -2.4% | -1.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11 | Citigroup | Maintains | Buy → Buy | — | $6.84 | $6.88 | +0.6% | +2.9% | -1.0% | +2.9% | +1.1% | +3.0% |
| Mar 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.71 | $6.66 | -0.7% | +1.9% | +2.9% | -1.0% | +2.9% | +1.1% |
| Mar 4 | Piper Sandler | Downgrade | Overweight → Neutral | — | $7.07 | $6.78 | -4.1% | -0.7% | +1.4% | -10.0% | +4.7% | +1.9% |
| Feb 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.31 | $7.48 | +2.3% | +1.2% | +13.8% | -5.8% | -2.1% | -1.7% |
| Dec 10 | Citigroup | Maintains | Buy → Buy | — | $4.23 | $4.55 | +7.6% | +19.6% | -2.0% | +1.8% | +1.2% | +0.6% |
| Nov 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.82 | $3.85 | +0.8% | -4.5% | +6.8% | -4.1% | +6.1% | -4.8% |
| Oct 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.20 | $4.27 | +1.7% | -3.8% | +4.2% | +0.5% | -1.7% | +1.0% |
| Sep 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.48 | $3.55 | +2.0% | +1.4% | -1.1% | +3.2% | +2.5% | +5.7% |
| Apr 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.64 | $2.67 | +1.1% | +2.7% | -5.5% | +2.3% | -0.8% | +0.0% |
| Mar 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.65 | $2.66 | +0.4% | +0.4% | -1.5% | -0.8% | +0.0% | +0.4% |
| Nov 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.30 | $2.31 | +0.4% | +0.9% | +9.1% | +13.0% | -2.1% | +0.0% |
| Oct 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.21 | $2.24 | +1.4% | +1.8% | -1.3% | -0.9% | +0.5% | +5.4% |
| Oct 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.25 | $2.20 | -2.2% | -2.2% | -1.4% | +0.5% | +4.6% | +0.9% |
| Aug 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.16 | $2.16 | +0.0% | +0.9% | +0.0% | +2.3% | -1.3% | +2.7% |
| Aug 15 | Piper Sandler | Maintains | Overweight → Overweight | — | $2.11 | $2.12 | +0.5% | +6.6% | -3.1% | -0.9% | +0.9% | +0.0% |
| Jun 26 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.16 | $2.35 | +8.8% | +2.3% | -7.2% | +23.4% | +0.8% | -14.5% |
| May 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.71 | $2.72 | +0.4% | +0.0% | -2.2% | -4.5% | -2.4% | +0.0% |
| May 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.65 | $2.68 | +1.1% | +0.8% | +6.0% | -4.2% | +0.0% | +0.0% |
| Mar 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.00 | $3.00 | +0.0% | -3.3% | +0.7% | -2.7% | +0.4% | +1.1% |
| Mar 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $3.03 | $3.00 | -1.0% | -0.7% | -0.3% | -3.3% | +0.7% | -2.7% |
| Nov 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.05 | $2.98 | -2.3% | -4.9% | -3.8% | +7.2% | +1.7% | +0.7% |
| Nov 17 | Piper Sandler | Maintains | Overweight → Overweight | — | $2.93 | $2.93 | +0.0% | +4.1% | -4.9% | -3.8% | +7.2% | +1.7% |
| Sep 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.35 | $3.39 | +1.2% | +3.3% | -7.5% | +2.5% | -9.1% | +2.3% |
| Aug 29 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $3.25 | $3.27 | +0.6% | +3.1% | -2.7% | +0.6% | +9.5% | -6.4% |
| Aug 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.25 | $3.27 | +0.6% | +3.1% | -2.7% | +0.6% | +9.5% | -6.4% |
| Aug 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.60 | $4.10 | +13.9% | +2.8% | -4.3% | +2.0% | -1.4% | -4.5% |
| May 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.71 | $3.62 | -2.4% | +3.5% | -1.6% | +2.4% | +1.3% | +1.3% |
| May 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.35 | $3.46 | +3.3% | +3.0% | +4.1% | +10.9% | -6.8% | +3.5% |
| May 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.87 | $4.10 | +5.9% | -3.1% | -9.6% | -1.2% | +3.0% | +4.1% |
| Apr 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.85 | $3.00 | +5.3% | +8.1% | +4.9% | -8.4% | -1.4% | +4.8% |
| Nov 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $3.75 | $3.84 | +2.4% | +3.2% | +20.4% | -9.9% | -4.8% | -0.2% |
| Apr 14 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $10.58 | $10.38 | -1.9% | -10.5% | +7.7% | -2.6% | -10.3% | +14.1% |
| Apr 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $11.20 | $11.62 | +3.8% | +0.4% | -11.4% | +6.8% | -0.6% | -10.5% |
| Apr 4 | Citigroup | Maintains | Buy → Buy | — | $10.54 | $11.86 | +12.5% | +13.5% | +5.9% | -3.4% | -8.5% | +0.4% |
No insider trades available.
No recent filings available.
Data updated apr 25, 2026 5:47am
· Source: massive.com